- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Severe Non-alcoholic fatty liver disease linked to hypertension
The risk of hypertension is higher in adults with severe non-alcoholic fatty liver disease, according to a recent study published in Clinical and Experimental Gastroenterology. The prevalence of severe NAFLD in adults with hypertension and obesity is 68.9%, researchers recently reported in this study. The lead researcher of this study Hypertension and Histopathology Severity of Non-Alcoholic Fatty Liver Disease Among Adults with Obesity: A Cross-Sectional Study is Dr. Diego Chambergo-Michilot.
Cardiovascular diseases are responsible for most deaths due to non-alcoholic fatty liver disease (NAFLD), associated with hypertension, a crucial predictor of severe liver outcomes, and an indicator of nonspecific portal fibrosis. The present study aimed to determine the association between hypertension and NAFLD severity using secondary data analysis from Peruvian adults with obesity and NAFLD (Peruvian bariatric centre).
The Fatty Liver Inhibition of Progression algorithm and the Steatosis, Activity and Fibrosis score were used to assess the severity of NAFLD. At the same time, hypertension was determined by either being recorded in medical records or having a systolic pressure ≥ 140 mmHg or diastolic pressure ≥ 90 mmHg.
Some of the important points of the study summary are:
- The study had 234 participants.
- The prevalence of hypertension and severe NAFLD was 19.2% and 46.2%, respectively.
- The prevalence of hypertension was higher in the severe NAFLD group than in the non-severe group.
- When stratified by the presence of metabolic syndrome (MetS), the association remained significant only in the group without MetS.
- In our study, they said we found an association between hypertension and severe NAFLD in adults with obesity, particularly in those without MetS.
Antihypertensives may reduce the fibrosis degree in the liver. They added that we did not collect the information about drug use, frequency and dose.
Limitations included study in a single-centre in a Latin American country, statistical limitations, etc.
This study was self-funded, they acknowledged.
Further reading:
BDS, MDS in Periodontics and Implantology
Dr. Aditi Yadav is a BDS, MDS in Periodontics and Implantology. She has a clinical experience of 5 years as a laser dental surgeon. She also has a Diploma in clinical research and pharmacovigilance and is a Certified data scientist. She is currently working as a content developer in e-health services. Dr. Yadav has a keen interest in Medical Journalism and is actively involved in Medical Research writing.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751